Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2022-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$406.7m
reported value
-4.3% vs Q3 2021
13positions
93.9%in top 10
1 new
7 added
1 reduced
1 sold out
vs Q3 2021
Options: 0 call positions (— notional), 1 put positions ($475.0m notional) – listed below, not included above.
Holdings, Q4 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SPERO THERAPEUTICS INC SPRO | $79.5m19.54% | Added +400.5k |
| BLUEPRINT MEDICINES CORP BPMC | $69.1m17.00% | Added +123.9k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $46.4m11.42% | Added +172.5k |
| ARVINAS INC ARVN | $46.3m11.38% | Added +208.7k |
| REGENXBIO INC RGNX | $33.1m8.15% | Added +174.5k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $33.1m8.14% | Added +410.0k |
| MERUS N V MRUS | $28.5m7.01% | New |
| AMRYT PHARMA PLC SPONSORED ADS | $17.7m4.35% | Added +250.0k |
| UNIQURE NV QURE | $14.0m3.45% | Reduced -643.3k |
| MAGENTA THERAPEUTICS INC COM | $14.0m3.44% | Unchanged |
| PIERIS PHARMACEUTICALS INC COM | $12.1m2.97% | Unchanged |
| ARGENX SE ARGX | $7.8m1.91% | Unchanged |
| GENMAB A/S GMAB | $5.0m1.24% | Unchanged |
Sold out since Q3 2021
| Security | Value then |
|---|---|
| DICERNA PHARMACEUTICALS INC DRNA | $49.5m2.5m shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $475.0m1.0m shares | New |
Trades reported as a company insider in Q4 2021
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2021-12-31 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $2.0m125.0k shares |
| 2021-12-30 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $788.5k50.0k shares |
| 2021-12-29 | SPERO THERAPEUTICS INC 10% owner · See footnotes | Bought | $1.1m75.5k shares |
| 2021-10-29 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $2.6m150.0k shares |